Harpagoside, ROTICHROM® Working Standard, 50 mg, conditionnement en verre

4-Chloroimidazo[2,1-f][1,2,4]triazine, 95.0%, 500mg

Orcéine, 25 g

(2S)-2-AMINO-2-(4-IODOPHENYL)ETHAN-1-OL HCL, 95.0%, 250mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-acetamidopentanoic acid, 98%, 250mg

3-Pyridin-2-yl-[1,2,4]oxadiazole-5-carboxylic acid ethyl ester, 95.0%, 1g

1-Benzyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,6-tetrahydropyridine, 95.0%, 25g

3-Acetyl-3-methyldihydrofuran-2(3H)-one, 95.0%, 1g

Debutyldronedarone (hydrochloride), 25mg

1-Bromo-3,6,9,12-tetraoxapentadec-14-yne, 95%, 100mg

4-Bromo-2-formylthiazole, 97.0%, 5g

1,2-benzisoxazol-7-ol, 95%, 25g

tert-butyl 4-amino-1,4'-bipiperidine-1'-carboxylate, 95.0%, 10g